D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 73 Citations 17,288 229 World Ranking 1025 National Ranking 31
Medicine D-index 73 Citations 17,402 236 World Ranking 15886 National Ranking 660

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Internal medicine

P. Richard Harrigan mainly focuses on Immunology, Virology, Acquired immunodeficiency syndrome, Viral load and Drug resistance. His Immunology research includes themes of Incidence and Cohort study. P. Richard Harrigan has included themes like Reverse transcriptase and Maraviroc in his Virology study.

P. Richard Harrigan combines subjects such as Viral disease and Mortality rate, Internal medicine with his study of Acquired immunodeficiency syndrome. The Viral load study combines topics in areas such as Genotyping and Genome. His Drug resistance research integrates issues from Odds ratio, HIV drug resistance, Antiretroviral therapy and Pharmacotherapy.

His most cited work include:

  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)
  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)
  • Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients (494 citations)

What are the main themes of his work throughout his whole career to date?

P. Richard Harrigan spends much of his time researching Virology, Immunology, Viral load, Internal medicine and Drug resistance. His work carried out in the field of Virology brings together such families of science as Genetics, Reverse transcriptase and Genotype. His research in Immunology intersects with topics in Prospective cohort study, Acquired immunodeficiency syndrome, Antiretroviral therapy and Cohort.

His work in Acquired immunodeficiency syndrome covers topics such as Viral disease which are related to areas like Immunopathology. His biological study spans a wide range of topics, including Viremia and Cohort study. His research in Drug resistance focuses on subjects like HIV drug resistance, which are connected to Protease inhibitor.

He most often published in these fields:

  • Virology (47.37%)
  • Immunology (44.13%)
  • Viral load (31.98%)

What were the highlights of his more recent work (between 2015-2021)?

  • Virology (47.37%)
  • Drug resistance (27.94%)
  • Internal medicine (31.17%)

In recent papers he was focusing on the following fields of study:

Virology, Drug resistance, Internal medicine, Acquired immunodeficiency syndrome and Viral load are his primary areas of study. His Virology study combines topics from a wide range of disciplines, such as Dolutegravir, First line and Genotype. His Drug resistance research is multidisciplinary, incorporating elements of Odds ratio, HIV drug resistance, Antiretroviral therapy, Cross-resistance and Data science.

In his study, Sexual transmission, Incidence and Psychological intervention is strongly linked to Harm reduction, which falls under the umbrella field of Acquired immunodeficiency syndrome. His Viral load study is concerned with the field of Immunology as a whole. His Immunology study frequently links to related topics such as Logistic regression.

Between 2015 and 2021, his most popular works were:

  • Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study (107 citations)
  • Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis. (73 citations)
  • Impact of pre-Adapted HIV transmission (62 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Acquired immunodeficiency syndrome

P. Richard Harrigan focuses on Virology, Acquired immunodeficiency syndrome, Transmission, Drug resistance and Viral load. His studies deal with areas such as Longitudinal study, Dolutegravir, Antiretroviral therapy, T cell and Viral genetics as well as Virology. P. Richard Harrigan has researched Acquired immunodeficiency syndrome in several fields, including Effective population size, NS5B, Genotype, Hepacivirus and Epidemiological Monitoring.

His Drug resistance research incorporates elements of Sanger sequencing, Data science and Hiv resistance. His Viral load study contributes to a more complete understanding of Immunology. His study in the fields of Immune system under the domain of Immunology overlaps with other disciplines such as Disease cluster.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)

928 Citations

Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients

Hélène C F Côté;Zabrina L Brumme;Kevin J P Craib;Christopher S Alexander.
The New England Journal of Medicine (2002)

713 Citations

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)

665 Citations

Predictors of HIV Drug-Resistance Mutations in a Large Antiretroviral-Naive Cohort Initiating Triple Antiretroviral Therapy

P. Richard Harrigan;Robert S. Hogg;Winnie W. Y. Dong;Benita Yip.
The Journal of Infectious Diseases (2005)

549 Citations

Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.

Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan.
Annals of Internal Medicine (2003)

472 Citations

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study

Evan Wood;Thomas Kerr;Brandon D L Marshall;Kathy Li.
BMJ (2009)

400 Citations

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho.
PLOS Medicine (2005)

384 Citations

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

David R Bangsberg;Edward P Acosta;Reena Gupta;David Guzman.
AIDS (2006)

378 Citations

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting

Julio S.G. Montaner;Viviane D. Lima;P. Richard Harrigan;Lillian Lourenço.
PLOS ONE (2014)

366 Citations

Molecular and Clinical Epidemiology of CXCR4-Using HIV-1 in a Large Population of Antiretroviral-Naive Individuals

Zabrina L. Brumme;Zabrina L. Brumme;James Goodrich;Howard B. Mayer;Chanson J. Brumme.
The Journal of Infectious Diseases (2005)

348 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing P. Richard Harrigan

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 360

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 208

Evan Wood

Evan Wood

University of British Columbia

Publications: 175

Thomas Kerr

Thomas Kerr

University of British Columbia

Publications: 161

Zabrina L. Brumme

Zabrina L. Brumme

Simon Fraser University

Publications: 140

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 132

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 86

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 85

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 81

Jonathan M. Carlson

Jonathan M. Carlson

Microsoft (United States)

Publications: 77

Mark A. Brockman

Mark A. Brockman

Simon Fraser University

Publications: 70

Deenan Pillay

Deenan Pillay

University College London

Publications: 69

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 68

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 63

David R. Bangsberg

David R. Bangsberg

Oregon Health & Science University

Publications: 62

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 60

Trending Scientists

Salah Sukkarieh

Salah Sukkarieh

University of Sydney

Jiang Wu

Jiang Wu

University of Electronic Science and Technology of China

Charles Whitmer

Charles Whitmer

Microsoft (United States)

Kazuhiko Endo

Kazuhiko Endo

National Institute of Advanced Industrial Science and Technology

Shijie Liu

Shijie Liu

SUNY College of Environmental Science and Forestry

Albertus P. H. J. Schenning

Albertus P. H. J. Schenning

Eindhoven University of Technology

Shinichi Aizawa

Shinichi Aizawa

Kumamoto University

K. Christopher Garcia

K. Christopher Garcia

Stanford University

Ali Amara

Ali Amara

Université Paris Cité

Christian Grefkes

Christian Grefkes

University of Cologne

Per thor Straten

Per thor Straten

University of Copenhagen

David Swinney

David Swinney

University of California, San Diego

Nelson B. Schiller

Nelson B. Schiller

University of California, San Francisco

Timothy J. Craig

Timothy J. Craig

Pennsylvania State University

Karen J. Hofman

Karen J. Hofman

University of the Witwatersrand

Samuel B. Bacharach

Samuel B. Bacharach

Cornell University

Something went wrong. Please try again later.